Loreto Boix
Barcelona, CT, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
miR-122 Deficiency in Mice Enhances Regeneration in Healthy Liver but Drives Pathological Repair and Functional Decline in Fibrotic Liver.
Journal: International journal of molecular sciences
Published: February 26, 2026
Correction: Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages.
Journal: Frontiers in immunology
Published: January 29, 2026
Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second-Line (The GOING Trial).
Journal: Alimentary pharmacology & therapeutics
Published: December 08, 2025
Association of Epigenetic Aging Biomarkers With Risk of MASLD-Related HCC.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: August 18, 2025
Polymeric nanoparticles for liver-targeted pituitary tumor-transforming gene 1 silencing in rats with chronic liver disease.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: June 18, 2025
Lymphocyte exhaustion in hepatocellular carcinoma: a dynamic evolution across disease stages.
Journal: Frontiers in immunology
Published: April 14, 2025
Genome-wide DNA methylation markers associated with metabolic liver cancer.
Journal: medRxiv : the preprint server for health sciences
Published: November 28, 2024
Genome-Wide DNA Methylation Markers Associated With Metabolic Liver Cancer.
Journal: Gastro hep advances
Published: October 24, 2024
Dynamic changes in immune cell populations by AXL kinase targeting diminish liver inflammation and fibrosis in experimental MASH.
Journal: Frontiers in immunology
Published: March 13, 2024
Metallothionein-3 is a multifunctional driver that modulates the development of sorafenib-resistant phenotype in hepatocellular carcinoma cells.
Journal: Biomarker research
Published: March 12, 2024
Induction of the Inflammasome Pathway by Tyrosine Kinase Inhibitors Provides an Actionable Therapeutic Target for Hepatocellular Carcinoma.
Journal: Cancers
Published: February 27, 2024
Identification of Dhx15 as a Major Regulator of Liver Development, Regeneration, and Tumor Growth in Zebrafish and Mice.
Journal: International journal of molecular sciences
Published: February 26, 2024
Last Updated: 09/26/2026